EBERSBERG, Germany--(BUSINESS WIRE)--March 24, 2004--MWG Biotech AG (FWB:NWU), Germany, announces the conclusion of a worldwide framework agreement with Pfizer Inc., New York, NY, USA. In the framework of this agreement MWG Biotech AG is "Partner of Choice" for supplying the products and services of the MWG Biotech business units Genomic Information (sequencing), Genomic Synthesis (oligonucleotides, synthetic nucleic acids), and Genomic Diagnosis (microarrays) to Pfizer Inc. Financial and other details were not disclosed.
MWG Biotech AG, Ebersberg Ulrike Schramm Public Relations Tel. +49-8092-8289-929 Email: email@example.com
Source: MWG Biotech AG